نتائج البحث 81-90 من 16837 لعملية البحث عن multiple%20sclerosis
Immune Phenotyping in Amyotrophic Lateral Sclerosis. Rochester, Minn. The goals of this study are to identify biomarkers that allow improved staging or ...
Rafid Mustafa, M.D.. Neurologist. Rochester, MN. مناطق التركيز: Stroke, Meningitis, Brain tumor, Multiple sclerosis, Transverse myelitis, Guillain Barre ...
Medicines and therapies. Targeted therapy. What it is: Belzutifan (Welireg) is a newer medication approved for people with VHL disease who develop multiple ...
Mayo Clinic is the No. 1 hospital in the world., with campuses in Arizona, Florida, and Minnesota.
The purpose of this study is to develop a natural history dataset and biorepository of early Primary Lateral Sclerosis (PLS) and well-established PLS cases for ...
rehabilitation, Parkinson's disease, Concussion, Brain cancer, Brain tumor, Multiple sclerosis, Muscular dystrophy, Balance problem, Dystonia, Movement ...
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at early clinical ...
A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS).
Juvenile primary lateral sclerosis. Genetic and Rare Diseases Information Center. https://rarediseases.info.nih.gov/diseases/4485/juvenile-primary-lateral- ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.